HRP20201050T1 - Derivati diarilmetiliden-piperidina i njihova primjena kao agonista delta opioidnih receptora - Google Patents

Derivati diarilmetiliden-piperidina i njihova primjena kao agonista delta opioidnih receptora Download PDF

Info

Publication number
HRP20201050T1
HRP20201050T1 HRP20201050TT HRP20201050T HRP20201050T1 HR P20201050 T1 HRP20201050 T1 HR P20201050T1 HR P20201050T T HRP20201050T T HR P20201050TT HR P20201050 T HRP20201050 T HR P20201050T HR P20201050 T1 HRP20201050 T1 HR P20201050T1
Authority
HR
Croatia
Prior art keywords
compound
formula
receptor agonists
opioid receptor
piperidine derivatives
Prior art date
Application number
HRP20201050TT
Other languages
English (en)
Inventor
Bengt Von Mentzer
Ingemar Starke
Peter Brandt
Original Assignee
Pharmnovo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmnovo Ab filed Critical Pharmnovo Ab
Publication of HRP20201050T1 publication Critical patent/HRP20201050T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Claims (6)

1. Spoj formule I [image]
2. Spoj formule I prema točki 1 zahtjeva za primjenu u bolnim stanjima.
3. Spoj formule I prema točki 2 zahtjeva pri čemu su bolna stanja vezana uz akutnu bol.
4. Spoj formule I prema točki 2 zahtjeva pri čemu su bolna stanja vezana uz kroničnu bol.
5. Spoj formule I prema točki 4 zahtjeva pri čemu su stanja vezana uz kroničnu boli u zglobovima, kao što su bolna stanja uzrokovana osteoartritisom ili fibromijalgijom.
6. Farmaceutski sastav koji kao aktivni sastojak sadrži barem spoj formule I u skladu s točkom 1 zahtjeva ili njezinu fiziološki prihvatljivu sol zajedno s farmaceutski prihvatljivim nosačem.
HRP20201050TT 2014-12-19 2020-07-03 Derivati diarilmetiliden-piperidina i njihova primjena kao agonista delta opioidnih receptora HRP20201050T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1451616 2014-12-19
EP15870465.0A EP3233825B1 (en) 2014-12-19 2015-12-17 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
PCT/SE2015/051363 WO2016099393A1 (en) 2014-12-19 2015-12-17 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists

Publications (1)

Publication Number Publication Date
HRP20201050T1 true HRP20201050T1 (hr) 2020-10-30

Family

ID=56127081

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20201050TT HRP20201050T1 (hr) 2014-12-19 2020-07-03 Derivati diarilmetiliden-piperidina i njihova primjena kao agonista delta opioidnih receptora

Country Status (16)

Country Link
US (1) US10118921B2 (hr)
EP (1) EP3233825B1 (hr)
JP (1) JP6691135B2 (hr)
CN (1) CN107531670B (hr)
AU (1) AU2015363757B2 (hr)
CA (1) CA2970256C (hr)
DK (1) DK3233825T3 (hr)
ES (1) ES2808667T3 (hr)
HR (1) HRP20201050T1 (hr)
HU (1) HUE050241T2 (hr)
LT (1) LT3233825T (hr)
PL (1) PL3233825T3 (hr)
PT (1) PT3233825T (hr)
RS (1) RS60744B1 (hr)
SI (1) SI3233825T1 (hr)
WO (1) WO2016099393A1 (hr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022013153A1 (en) 2020-07-17 2022-01-20 Pharmnovo Ab Polymorphs of a hydrochloride salt of pn6047

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0101771D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101768D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0103313D0 (sv) 2001-10-03 2001-10-03 Astrazeneca Ab Novel compounds
SE0300987D0 (sv) * 2003-04-03 2003-04-03 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0301445D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof

Also Published As

Publication number Publication date
WO2016099393A1 (en) 2016-06-23
EP3233825A1 (en) 2017-10-25
US10118921B2 (en) 2018-11-06
PL3233825T3 (pl) 2020-11-02
RS60744B1 (sr) 2020-10-30
AU2015363757B2 (en) 2019-11-14
DK3233825T3 (da) 2020-06-29
JP2018501314A (ja) 2018-01-18
CA2970256C (en) 2022-03-29
LT3233825T (lt) 2020-08-10
JP6691135B2 (ja) 2020-04-28
US20170327491A1 (en) 2017-11-16
CA2970256A1 (en) 2016-06-23
AU2015363757A1 (en) 2017-08-03
SI3233825T1 (sl) 2020-10-30
ES2808667T3 (es) 2021-03-01
PT3233825T (pt) 2020-07-15
EP3233825A4 (en) 2018-08-15
CN107531670B (zh) 2020-12-15
HUE050241T2 (hu) 2020-11-30
EP3233825B1 (en) 2020-04-29
CN107531670A (zh) 2018-01-02

Similar Documents

Publication Publication Date Title
HRP20221294T1 (hr) Neuroaktivni steroidi, njihovi pripravci i uporabe
HRP20160135T1 (hr) Derivati 2-(2,4,5-supstituiranog-anilino) pirimidina kao modulatori egfr koji su korisni za lijeäśenje raka
CL2015000578A1 (es) Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer.
MX369818B (es) Compuestos selectivos de peptido yy (pyy) y usos de los mismos.
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
EA201690287A1 (ru) 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом
EP4309735A3 (en) Pharmaceutical composition of s-ketamine hydrochloride
HRP20220759T1 (hr) Pripravci i postupci koji ih koriste za liječenje neurodegenerativne i mitohondrijske bolesti
CY1123372T1 (el) Απο toy στοματος φαρμακευτικη συνθεση
EA029499B9 (ru) Ингибиторы rorc2 и способы их применения
EP3412292B8 (en) Use of methoxatin, derivative and/or salt thereof in sjogren's syndrome and pharmaceutical composition
EA202091262A1 (ru) Пиперидиновые модуляторы рецепторов cxcr7
EP2987786A4 (en) AMIDOPYRIDINOL DERIVATIVE OR PHARMACEUTICAL, SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE SUBSTANCE
IL282163A (en) A pharmaceutical preparation for oral administration containing an aminopyrimidine derivative or its salt
AR090975A1 (es) N-etil-4-hidroxil-1-metil-5-(metil(2,3,4,5,6-pentahidroxihexil)amino)-2-oxo-n-fenil-1,2-dihidroquinolina-3-carboxamida
HRP20201050T1 (hr) Derivati diarilmetiliden-piperidina i njihova primjena kao agonista delta opioidnih receptora
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
EA201691231A1 (ru) Фармацевтические лекарственные формы
EP3530654A4 (en) CARBOXYLIC ACID COMPOUND WITH QUINOLINYL SUBSTITUTE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF
JOP20180071B1 (ar) استخدام مشتقات أمينو ألكيل بنزوثيازبين
JOP20200127A1 (ar) مشتقات بيريدينون واستخدامها كمثبطات alk-2 انتقائية
HRP20171514T1 (hr) Derivati indolouree supstituirani glukopiranozilom i njihova upotreba kao inhibitora sglt
BR112014022687A2 (pt) Uso de uma quantidade eficaz de r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo, composição farmacêutica, r-p88 ou um sal farmaceuticamente aceitável do mesmo, ou um éster do mesmo ou um sal farmaceuticamente aceitável de um éster do mesmo
RU2012100120A (ru) Акарицидная фармацевтическая композиция на основе соли четвертичного фосфония, замещенного динитробензофураксана и ксимедонгидрохлорида
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof